Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ B · Shares Outstanding. M · Public Float. M · Yield. VIR is not. Get the latest updates on Vir Biotechnology, Inc. Common Stock (VIR) pre market trades, share volumes, and more. Make informed investments with Nasdaq. Paramount Group Inc. $ PGRE % ; In the news. Yahoo Finance. 1 day ago. Vir Biotechnology to Participate in the Morgan Stanley 22nd Annual Global. Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond.
Vir's core capabilities include our deep immunology and virology expertise, our proven world-class monoclonal antibody platform with AI-led protein engineering. Research Vir Biotechnology's (Nasdaq:VIR) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Vir Biotechnology Inc VIR:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date06/05/24 · 52 Week Low · Vir Biotechnology, Inc. (profhimservice76.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Vir Biotechnology, Inc. | Nasdaq. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. VIR will report earnings. Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide financial results for the second quarter ended June 30, , on August 1, Vir Biotechnology Inc. ; Volume, M ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. Ratings Valuation (Hist. Mult.) Upgrade. Profile. Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and. On average, Wall Street analysts predict that Vir Biotechnology's share price could reach $ by Aug 20, The average Vir Biotechnology stock price. Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases. Vir Biotechnology Inc. ; Open. ; High. ; 52wk High. ; Volume. k ; Beta.
Why Shares of Vir Biotechnology Rose % This Week Joining the S&P SmallCap could boost the company's profile. Why Vir Biotechnology Stock Is. VIR | Complete Vir Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The 35 analysts offering price forecasts for Vir Biotechnology have a median target of , with a high estimate of and a low estimate of Vir Biotechnology Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Volume, M. Market Value, $B. Shares Outstanding, M. EPS (TTM), -$ P/E Ratio (TTM), N/A. Dividend Yield, N/A. Latest Dividend, N/A. Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. NASDAQ: VIR See the latest Vir Biotechnology Inc stock price (VIR:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Stock analysis for Vir Biotechnology Inc (VIR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. VIR will report earnings. Discover real-time Vir Biotechnology, Inc. Common Stock (VIR) stock prices, quotes, historical data, news, and Insights for informed trading and investment. Find annual and quearterly earnings data for Vir Biotechnology, Inc. Common Stock (VIR) including earnings per share, earnings forecasts at profhimservice76.ru Vir Biotechnology Inc ; Sep, Initiated, Morgan Stanley, Underweight, $15 ; Mar, Upgrade, Robert W. Baird, Underperform → Neutral, $36 → $ The current price of VIR is USD — it has increased by % in the past 24 hours. Watch Vir Biotechnology, Inc. stock price performance more closely on the.
Waaree Renewables Share Latest News - Waaree Renewables Share Analysis - Renewable Sector News
Discover all the factors affecting Vir Biotechnology's share price. VIR is currently rated as a Falling Star | Stockopedia. Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The Vir Biotechnology, Inc. stock price is closed at $ with a total market cap valuation of $ B (M shares outstanding). The Vir Biotechnology. Vir Biotechnology, Inc. (Nasdaq: VIR) is a prominent immunology company pioneering the use of advanced technological innovations to address some of the globe's. Vir Biotechnology, Inc. (US:VIR) has institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).